HE4 displayed a balanced diagnostic profile with a sensitivity of 0.73 (95% CI: 0.68–0.77) and a specificity of 0.83 (95% CI: 0.78–0.87), making it a strong overall candidate for NSCLC diagnosis. Here, WFDC2 is linked to non-small cell lung carcinoma.